0FDB

Navamedic Asa (0FDB)

Navamedic Asa

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0FDB

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/12/22	01 : 29	PR Newswire (US)	Navamedic ASA: Renewed contract signed with Vitaflo International Limited	LSE:0FDB	Navamedic Asa
2023/12/14	03 : 18	PR Newswire (US)	Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in Europe	LSE:0FDB	Navamedic Asa
2023/11/01	16 : 14	PR Newswire (US)	Navamedic ASA: Record high quarter with above 50 percent growth	LSE:0FDB	Navamedic Asa
2023/10/27	18 : 52	PR Newswire (US)	Navamedic ASA: Invitation to 2023 3rd quarter presentation	LSE:0FDB	Navamedic Asa
2023/08/30	20 : 20	PR Newswire (US)	Navamedic ASA - Registration of share capital increase	LSE:0FDB	Navamedic Asa
2023/08/18	19 : 50	PR Newswire (US)	Navamedic ASA - Mandatory notification of trade by primary insider	LSE:0FDB	Navamedic Asa
2023/08/18	19 : 27	PR Newswire (US)	NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee options	LSE:0FDB	Navamedic Asa
2023/08/11	15 : 41	PR Newswire (US)	Navamedic ASA: Significant growth across the business	LSE:0FDB	Navamedic Asa
2023/08/07	19 : 40	PR Newswire (US)	Navamedic ASA: Invitation to 2023 2nd quarter presentation	LSE:0FDB	Navamedic Asa
2023/06/01	18 : 43	PR Newswire (US)	Navamedic ASA: Minutes of Annual General Meeting	LSE:0FDB	Navamedic Asa
2023/05/31	21 : 42	PR Newswire (US)	Updated recommendation by the nomination committee of Navamedic ASA	LSE:0FDB	Navamedic Asa
2023/05/26	15 : 23	PR Newswire (US)	Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer	LSE:0FDB	Navamedic Asa
2023/05/11	19 : 15	PR Newswire (US)	Navamedic ASA: Notice of Annual General Meeting	LSE:0FDB	Navamedic Asa
2023/05/11	15 : 57	PR Newswire (US)	Navamedic ASA Q1 2023: Another strong quarter	LSE:0FDB	Navamedic Asa
2023/05/10	16 : 15	PR Newswire (US)	Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose Aktiebolag	LSE:0FDB	Navamedic Asa
2023/05/08	18 : 25	PR Newswire (US)	Navamedic ASA: Invitation to 2023 1st quarter presentation	LSE:0FDB	Navamedic Asa
2023/04/28	20 : 57	PR Newswire (US)	Navamedic ASA: Annual Report for 2022	LSE:0FDB	Navamedic Asa
2023/04/24	12 : 34	PR Newswire (US)	Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB	LSE:0FDB	Navamedic Asa
2023/03/29	15 : 13	PR Newswire (US)	Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million	LSE:0FDB	Navamedic Asa
2023/02/16	17 : 00	PR Newswire (US)	Navamedic ASA: Q4 2022 financial results	LSE:0FDB	Navamedic Asa
2023/02/13	17 : 19	PR Newswire (US)	Navamedic ASA: Invitation to 2022 4th quarter presentation	LSE:0FDB	Navamedic Asa
2022/11/23	19 : 30	PR Newswire (US)	Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region	LSE:0FDB	Navamedic Asa
2022/11/01	16 : 43	PR Newswire (US)	Navamedic ASA: Q3 2022 financial results	LSE:0FDB	Navamedic Asa
2022/10/25	23 : 01	PR Newswire (US)	Navamedic ASA: Invitation to 2022 third quarter presentation	LSE:0FDB	Navamedic Asa
2022/10/20	16 : 24	PR Newswire (US)	Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipation	LSE:0FDB	Navamedic Asa
2022/08/12	15 : 48	PR Newswire (US)	Navamedic ASA: Q2 and first half 2022 financial results	LSE:0FDB	Navamedic Asa
2022/08/09	21 : 40	PR Newswire (US)	Navamedic ASA: Invitation to 2022 second quarter presentation	LSE:0FDB	Navamedic Asa
2022/08/04	21 : 27	PR Newswire (US)	Navamedic ASA - Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®	LSE:0FDB	Navamedic Asa
2022/07/05	03 : 13	PR Newswire (US)	Navamedic ASA: Trading Update	LSE:0FDB	Navamedic Asa
2022/06/02	21 : 05	PR Newswire (US)	Navamedic ASA: Minutes of Annual General Meeting	LSE:0FDB	Navamedic Asa